Pharmaceutical industry seeks relief from rate inversion

The pharmaceutical industry in India anticipates potential relief from Goods and Services Tax inversion. Discussions between companies and the government suggest a favourable resolution within upcoming GST reforms. The current tax structure creates working capital issues, especially for MSMEs. Delayed refunds force MSMEs to take loans. Exporters face strain paying upfront taxes on APIs.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/tmQ3Cg8
via IFTTT